Neurobiogen Co., Ltd.

Megabiowood Co., Ltd

Min Ho Nam

Jong-Hyun Park

Dong Jin Kim

Ae Nim Pae

Ji Won Choi

Jun Young Heo

Yun Kyung Kim

ChangJoon Justin Lee

Ki Duk Park

Yong Koo Kang

Seul Ki Yeon

Sun Joon Min

Hyun Ah Choo

Hyo Jung Song

Bo Ko Jang

Eun Ji Ju

Seon Mi Jo

Jong-hyun Park

Changjoon Justin Lee

The present disclosure relates to an &#x3b1;-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.

Alpha-aminoamide derivative compound and pharmaceutical composition comprising same

The present disclosure relates to an &#x3b1;-aminoamide derivative compound and a pharmaceutical composition containing the same, for treating a neurodegenerative diseases.

Growing community of inventors

Seoul, South Korea

Min Ho Nam